BRAF V600E potentially determines “Oncological Resectability” for “Technically Resectable” colorectal liver metastases

Despite reports on poor survival outcomes after hepatectomy for colorectal liver metastases (CRLM) with BRAF V600E mutation (mBRAF) exist, the role of mBRAF testing for technically resectable cases remains unclear. A single‐center retrospective study was performed to investigate the survival outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Shin, Takahashi, Shinichiro, Nomura, Shogo, Kojima, Motohiro, Kudo, Masashi, Sugimoto, Motokazu, Konishi, Masaru, Gotohda, Naoto, Taniguchi, Hiroya, Yoshino, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Researcher
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525127/
https://www.ncbi.nlm.nih.gov/pubmed/34535965
http://dx.doi.org/10.1002/cam4.4227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525127/
https://www.ncbi.nlm.nih.gov/pubmed/34535965
http://dx.doi.org/10.1002/cam4.4227

Ejemplares similares